ANI制药

ANIP NASDAQ
80.75
-0.25
-0.31%
盘后: 80.75 0 0.00% 18:41 07/19 EDT
开盘
80.81
昨收
81.00
最高
81.39
最低
79.84
成交量
8.09万
成交均量(3M)
14.46万
52周最高
84.10
52周最低
36.92
换手率
0.67%
市值
9.73亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供ANI制药 ANIP股票价格,ANI制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Inderal LA, Lithobid, Reglan and Vancocin. Its pharmaceutical manufacturing facilities are located in Baudette, Minnesota.
展开 >

最近浏览

名称
价格
涨跌幅